These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 38309317)
41. Linc01133 promotes proliferation and metastasis of human renal cell carcinoma through sponging miR-760. Lv W; Li Y; Fu L; Meng F; Li J Cell Cycle; 2022 Jul; 21(14):1502-1511. PubMed ID: 35446199 [TBL] [Abstract][Full Text] [Related]
42. Retracted Article: lncRNA TINCR sponges miR-214-5p to upregulate ROCK1 in hepatocellular carcinoma. Hu M; Han Y; Zhang Y; Zhou Y; Ye L BMC Med Genet; 2020 Jan; 21(1):2. PubMed ID: 31900116 [TBL] [Abstract][Full Text] [Related]
43. Long Non-Coding RNA LOC648987 Promotes Proliferation and Metastasis of Renal Cell Carcinoma by Regulating Epithelial-Mesenchymal Transition. Su Y; Zhou L; Yu Q; Lu J; Liu W Technol Cancer Res Treat; 2021; 20():1533033821997834. PubMed ID: 33858283 [TBL] [Abstract][Full Text] [Related]
44. LncRNA IUR Is Downregulated in Gastric Carcinoma and Associated with Poor Survival. Ou R; Liu X Cancer Biother Radiopharm; 2023 Mar; 38(2):116-121. PubMed ID: 32783641 [No Abstract] [Full Text] [Related]
45. Upregulation of long noncoding RNA TUG1 contributes to the development of laryngocarcinoma by targeting miR-145-5p/ROCK1 axis. Zhuang S; Liu F; Wu P J Cell Biochem; 2019 Aug; 120(8):13392-13402. PubMed ID: 30916820 [TBL] [Abstract][Full Text] [Related]
46. Transfection with Plasmid-Encoding lncRNA-SLERCC nanoparticle-mediated delivery suppressed tumor progression in renal cell carcinoma. Mao W; Wang K; Zhang W; Chen S; Xie J; Zheng Z; Li X; Zhang N; Zhang Y; Zhang H; Peng B; Yao X; Che J; Zheng J; Chen M; Li W J Exp Clin Cancer Res; 2022 Aug; 41(1):252. PubMed ID: 35986402 [TBL] [Abstract][Full Text] [Related]
47. LINC00536 Promotes Breast Cancer Progression by Regulating ROCK1 via Sponging of miR-214-5p. Hu C; Zhang X; Fang K; Guo Z; Li L Biochem Genet; 2023 Jun; 61(3):1163-1184. PubMed ID: 36513954 [TBL] [Abstract][Full Text] [Related]
48. Hypoxia-induced lncHILAR promotes renal cancer metastasis via ceRNA for the miR-613/206/ 1-1-3p/Jagged-1/Notch/CXCR4 signaling pathway. Hu G; Ma J; Zhang J; Chen Y; Liu H; Huang Y; Zheng J; Xu Y; Xue W; Zhai W Mol Ther; 2021 Oct; 29(10):2979-2994. PubMed ID: 34058384 [TBL] [Abstract][Full Text] [Related]
49. Downregulation of long non-coding RNA DUXAP10 inhibits proliferation, migration, and invasion of renal cell carcinoma. Chen J; Wang XF; Qin YC; Gong YB; Wang L; Li NC Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11041-11051. PubMed ID: 33215419 [TBL] [Abstract][Full Text] [Related]
50. Long noncoding RNA UFC1 acts as an oncogene via stimulating EZH2-induced inhibition of APC expression in renal cell carcinoma. Wang J; Liu G Cell Mol Biol (Noisy-le-grand); 2023 Apr; 69(4):152-156. PubMed ID: 37329532 [TBL] [Abstract][Full Text] [Related]
51. Knockdown of Long Noncoding RNA FTX Inhibits Proliferation, Migration, and Invasion in Renal Cell Carcinoma Cells. He X; Sun F; Guo F; Wang K; Gao Y; Feng Y; Song B; Li W; Li Y Oncol Res; 2017 Jan; 25(2):157-166. PubMed ID: 27983937 [TBL] [Abstract][Full Text] [Related]
52. Long non-coding RNA DLEUI promotes papillary thyroid carcinoma progression by sponging miR-421 and increasing ROCK1 expression. Li R; Wan T; Qu J; Yu Y; Zheng R Aging (Albany NY); 2020 Sep; 12(20):20127-20138. PubMed ID: 32910787 [TBL] [Abstract][Full Text] [Related]
53. Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma. Wang Y; Zeng X; Wang N; Zhao W; Zhang X; Teng S; Zhang Y; Lu Z Mol Cancer; 2018 May; 17(1):89. PubMed ID: 29753317 [TBL] [Abstract][Full Text] [Related]
54. Long non-coding RNA CYTOR modulates cancer progression through miR-136-5p/MAT2B axis in renal cell carcinoma. Wang D; Zhu X; Siqin B; Ren C; Yi F Toxicol Appl Pharmacol; 2022 Jul; 447():116067. PubMed ID: 35597301 [TBL] [Abstract][Full Text] [Related]
55. Methyltransferase-like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1. Liu T; Wang H; Fu Z; Wang Z; Wang J; Gan X; Wang A; Wang L Cancer Sci; 2022 Feb; 113(2):446-458. PubMed ID: 34813676 [TBL] [Abstract][Full Text] [Related]
56. LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor(AR)/miRNA-143-3p signals. Zhai W; Sun Y; Guo C; Hu G; Wang M; Zheng J; Lin W; Huang Q; Li G; Zheng J; Chang C Cell Death Differ; 2017 Sep; 24(9):1502-1517. PubMed ID: 28644440 [TBL] [Abstract][Full Text] [Related]
57. Identification of lncRNA EGOT as a tumor suppressor in renal cell carcinoma. Jin L; Quan J; Pan X; He T; Hu J; Li Y; Gui Y; Yang S; Mao X; Chen Y; Lai Y Mol Med Rep; 2017 Nov; 16(5):7072-7079. PubMed ID: 28901455 [TBL] [Abstract][Full Text] [Related]
58. Overexpression of long non-coding RNA differentiation antagonizing non-protein coding RNA inhibits the proliferation, migration and invasion and promotes apoptosis of renal cell carcinoma. Jin L; Fu H; Quan J; Pan X; He T; Hu J; Li Y; Li H; Yang Y; Ye J; Zhang F; Ni L; Yang S; Lai Y Mol Med Rep; 2017 Oct; 16(4):4463-4468. PubMed ID: 28765964 [TBL] [Abstract][Full Text] [Related]
59. Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma. Wang Z; Chang X; Zhu G; Gao X; Chang L Cell Cycle; 2020 Aug; 19(16):2054-2062. PubMed ID: 32663095 [TBL] [Abstract][Full Text] [Related]
60. CARD10 promotes the progression of renal cell carcinoma by regulating the NF‑κB signaling pathway. Peng L; He K; Cao Z; Bi L; Yu D; Wang Q; Wang J Mol Med Rep; 2020 Jan; 21(1):329-337. PubMed ID: 31939627 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]